| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/22/2007 | WO2007022280A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | WO2007022268A2 Compounds and compositions as protein kinase inhibitors |
| 02/22/2007 | WO2007021710A1 Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 02/22/2007 | WO2007021574A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | WO2007020521A1 Pyridoyrazinones as pde-5 inhibitors |
| 02/22/2007 | WO2007020344A1 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 02/22/2007 | WO2007020343A1 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | WO2007019987A1 Substituted 8-(3-aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4,5]decan-4-on-derivatives for use in pain therapy |
| 02/22/2007 | WO2007019942A1 Metal complex |
| 02/22/2007 | WO2007019867A1 Novel 2,3-dihydroindole compounds |
| 02/22/2007 | WO2007019675A1 Indole derivatives as crth2 receptor antagonists |
| 02/22/2007 | WO2006135425A3 Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 02/22/2007 | WO2006128852A3 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 02/22/2007 | WO2006120252A3 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof |
| 02/22/2007 | WO2006070408B1 A process for the preparation of substantially pure 4-amino-1-isobutyl-1h-imidazo[4,5-c]-quinoline (imiquimod) |
| 02/22/2007 | WO2006068978A3 Dipeptidyl peptidase inhibitors |
| 02/22/2007 | WO2006062981A3 Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 02/22/2007 | WO2006059103A3 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 02/22/2007 | WO2006042102A3 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| 02/22/2007 | WO2006026754B1 Bicyclic heteroaryl pde4b inhibitors |
| 02/22/2007 | WO2005120516A3 Hiv integrase inhibitors |
| 02/22/2007 | WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same |
| 02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 02/22/2007 | US20070043080 Substituted anilinic piperidines as MCH selective antagonists |
| 02/22/2007 | US20070043074 2-(4-methylphenyl),3-(thien-2-yl-carbonyl),6-(methyl)imidazo(1,2-a)pyridine; GABA receptor inhibitors; anxiiolytic agents; sleep disorders (insomnia); psychological disorders; anticonvulsants; aggressiveness; antispasmodic agents; antidepressants/ bipolar disorders;cognition activators; analgesics |
| 02/22/2007 | US20070043073 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 02/22/2007 | US20070043072 Cancers that express nitric oxide synthase; 2-[2-(2-Amino-4-methylpyridin-6-yl)ethyl]-3H-imidazo[4,5-b]pyridine |
| 02/22/2007 | US20070043070 Weak base salts |
| 02/22/2007 | US20070043069 3-Amino-3,4-dihydro-1,5-naphthyridin-2(1H)-one and its dihydrochloride; intermediates for producing naphthyridinylaminocarbonyl-substituted pyrrolothiopyrans and imidazolothiopyrans |
| 02/22/2007 | US20070043068 Pyrrolo-pyridine kinase modulators |
| 02/22/2007 | US20070043063 Such as 3-(2-Methanesulfonyl-pyrimidin-4-yl)-5-pyridin-3-yl-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine; heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, hypertension, allergic diseases, autoimmune diseases, destructive bone disorders |
| 02/22/2007 | US20070043039 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | CA2619462A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | CA2619049A1 Compounds and compositions as protein kinase inhibitors |
| 02/22/2007 | CA2618614A1 Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 02/22/2007 | CA2618550A1 Indole derivatives as crth2 receptor antagonists |
| 02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | CA2618110A1 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 02/22/2007 | CA2617828A1 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation methodthereof and use of same in |
| 02/22/2007 | CA2617359A1 Compounds and compositions as protein kinase inhibitors |
| 02/22/2007 | CA2616308A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1753766A1 Tetraazabenzo(e)azulene derivatives and analogs thereof |
| 02/21/2007 | EP1753764A1 Pyrrolopyridine derivatives |
| 02/21/2007 | EP1753763A2 Indazole and indolone derivatives and their use as pharmaceuticals |
| 02/21/2007 | EP1753762A1 Lewis acid mediated synthesis of cyclic esters |
| 02/21/2007 | EP1753743A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals |
| 02/21/2007 | EP1753730A1 Dipeptidyl peptidase inhibitors |
| 02/21/2007 | EP1753718A1 3-amino-2-phenylpyrrolidine derivatives |
| 02/21/2007 | EP1753428A2 Kinase inhibitors as therapeutic agents |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | CN1918161A Tricyclic imidazopyridines and intermediates for the synthesis thereof |
| 02/21/2007 | CN1918160A Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 02/21/2007 | CN1918159A Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1) |
| 02/21/2007 | CN1918158A Compounds and compositions as protein kinase inhibitors |
| 02/21/2007 | CN1918149A Novel chelating agents and highly luminescent and stable chelates and their use |
| 02/21/2007 | CN1918145A Amino heterocyclic modulators of chemokine receptor activity |
| 02/21/2007 | CN1918141A Aminodibenzodioxin derivative and organic electroluminescent device using same |
| 02/21/2007 | CN1918137A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1917881A Novel phenylalanine derivatives |
| 02/21/2007 | CN1915995A S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 02/21/2007 | CN1915994A Indole group alkaloid of sector Gouyahua, and application for preparing drug-breaking medicine |
| 02/21/2007 | CN1915993A Indole group alkaloid of Hainan Gouyahua, and application for preparing drug-breaking medicine |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179919 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179820 Administering to an animal having ocular hypertension a piperidynly analog as for example 7-[2-oxo-6-((E)-3-oxo-oct-1-enyl)-piperidin-1-yl]-hept-5-ynoic acid methyl ester |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179811 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
| 02/20/2007 | US7179809 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| 02/20/2007 | US7179805 Microbiocides; bactericides |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | US7179542 a functional layer ( emissive layer, electron transport layer, hole transport, electron blocking, a hole blocking) is sandwiched between an anode and a cathode |
| 02/20/2007 | CA2325776C Novel analogue compounds of camptothecin, process for preparing them and pharmaceutical compositions containing them |
| 02/15/2007 | WO2007019345A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | WO2007019295A1 Methods of preparing quinolone analogs |
| 02/15/2007 | WO2007019126A2 Method of preparation of azaindole derivatives |
| 02/15/2007 | WO2007019083A1 Pyrimidine compounds as serotonin receptor modulators |
| 02/15/2007 | WO2007018998A2 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007018137A1 Multikinase inhibitor |
| 02/15/2007 | WO2007018004A1 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same |
| 02/15/2007 | WO2007017585A2 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 02/15/2007 | WO2007017584A1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 02/15/2007 | WO2007017577A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 02/15/2007 | WO2007017264A2 Pyrrolopyridinederivatives as modulators of the cannabinoid receptor for the treatment of immune and inflammatory disorders |
| 02/15/2007 | WO2007017237A1 Imidazopyridine derivatives as cannabinoid receptor ligands |
| 02/15/2007 | WO2007017143A1 Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 02/15/2007 | WO2007017083A1 Pyrazole derivatives having tyrosinkinase activity |
| 02/15/2007 | WO2006125180B1 Piperazine derivatives and their uses as therapeutic agents |